• 学术搜索
  • 科研智能体
    • Research Labs
    • AI 阅读
    • AI 文库
    • 深度研究
    • 学者亮点
  • 学术资源
    • AI2000
    • 期刊/会议
    • 学者库
    • 学术API
      MCP&Skill
    • 溯源树
    • 数据集
  • 知识沉淀
    • 学术空间
订阅小程序
旧版功能
aminer vip
开通会员低至0.73元/天
一次搞定AI科研
立即登录
  • English
  • 联系方式
    Health economics, policy, and law

    Health economics, policy, and law

    JournalISSN 1744-1331eISSN 1744-134X中科院 医学 2区

    年发文量

    研究主题

    论文(762)

    排序
    1Multiple Paths to Privatisation in Healthcare? Comparing England and Italy Beyond the Public–private Divide
    Neil Lunt,Federico Toth,Mark Exworthy

    English and Italian national health systems are predominantly funded by general taxation and treat patients primarily free at the point of delivery. Both healthcare systems are facing increasing financial pressures given population ageing, the rise in chronic and non-communicable diseases, and fiscal restraint. In recent years, pressures on public healthcare have revived debate around the role of the private sector, but discussion is mired in a lack of conceptual clarity. We seek to bring greater analytical order by distinguishing seven distinct 'trajectories of privatisation', each reflecting different modes and logics of interaction between public and private actors. We examine two similar health systems - England and Italy - highlight their similarities and differences regarding emerging and established trajectories. There is less evidence of 'hard privatisation', seen as the private share of overall spending; however, both countries are experiencing greater use of on-demand staff and financialisation. In both systems subtler privatisation dynamics (public-private partnerships, managerialism, and entrepreneurialism) are redefining and blurring the boundaries between public and private provision. Public perceptions of perceived privatisation are shaped by direct, tangible experiences of care and out-of-pocket spending. Some privatisation dynamics are mainly driven by behaviour of patients, professionals, and investors rather than by policies.

    2026
    引用
    AI阅读
    加入学术空间
    2Investment or Extraction? Reframing Private Equity in Healthcare
    Mary Bugbee

    Moral hazard is built into the structure of private equity investments, which incentivises debt-based extraction rather than value-adding investment. To craft effective regulation of private equity’s participation in healthcare, and to cut through the industry’s talking points, we must reframe and acknowledge private equity ‘investment’ as ‘extraction’. In the U.S. healthcare system, this debt-based extraction has produced higher risks of bankruptcy and financial distress and associated facility closures, cost-cutting that affects patient safety and care, rising healthcare costs, inefficient use of taxpayer dollars, erosion of clinician autonomy, and increased consolidation. Policies that address extractive behaviours are the most targeted and efficient means of safeguarding patient care and may discourage the worst actors from acquiring healthcare providers. As private equity invests in health systems beyond the U.S. where regulatory regimes differ, the fundamentals of its extractive business model remain the same. Regulations must be calibrated to country specifics, but they should address the debt-based extraction built into the very structure of private equity investments. As policy debates continue, it is worth asking why we need private equity’s extractive business model in healthcare in the first place.

    2026
    引用
    AI阅读
    加入学术空间
    3Litigating the No Surprises Act: How Legal Challenges Undermined Cost Containment and Reshaped Provider Payments
    Lindsey Murtagh, Ayesha Rahim,Erin Fuse Brown

    The No Surprises Act (NSA), signed into law by President Trump over five years ago, marked a significant federal intervention aimed at shielding millions of consumers with private health coverage from unexpected out-of-network medical bills. While the Act is lauded for successfully protecting consumers, its implementation has been plagued by aggressive litigation, with provider-led lawsuits challenging the Act itself as well as every rule issued to implement the protections and countless other lawsuits challenging actions (or inactions) by providers, insurers, and independent dispute resolution (IDR) entities. This litigation has profoundly impacted the Act’s cost-saving objectives by eroding its payment methodology and fostering extensive use of the IDR process. This paper chronicles the litigation timeline from the passage of the NSA through April 2026 and its impacts on the implementation, detailing the challenges to the regulatory framework and how adversarial legalism shaped the NSA’s trajectory. The paper concludes by offering policy options for Congress, federal agencies, states, and stakeholders to reduce costs and IDR volume to better align with the intent of the NSA.

    2026
    引用
    AI阅读
    加入学术空间
    4Mapping Digital Welfare Platforms Globally: Functional Typologies, Governance Gaps, and Policy Implications
    Agnese Palvarini

    This study presents the first comprehensive global mapping and inductive classification of digital welfare platforms. Drawing on an original dataset of 285 cases spanning diverse institutional and geographical contexts, it identifies five core functional types: service delivery, information repository, search engine, value co-creation, and community-building. Using a multidimensional descriptive approach and a structured decision-tree model, the analysis reveals significant divergence in governance arrangements, user orientation, monetisation strategies, and business models. While digital platforms are often promoted as tools for enhancing accessibility and efficiency, the findings expose critical systemic voids - particularly in public sector involvement, youth-focused provision, and accountability mechanisms. The study highlights the fragmented and commercially skewed nature of emerging digital welfare infrastructures, raising pressing concerns about equity, inclusion, and the normative trajectories shaping welfare governance in the platform era.

    2026
    引用
    AI阅读
    加入学术空间
    5Institutional Tensions in HIV Treatment: Challenges in Providing Free Antiretroviral Drugs under China’s ‘four Frees and One Care’ Policy
    Ziyi Xie,Kinglun Ngok, Zhenjie Yang,Zhizhuang Duan

    China’s ‘Four Frees and One Care’ policy provides people living with HIV (PLHIV) with free antiretroviral drugs (ARVs), while the recent inclusion of new ARVs in medical insurance policy has created policy overlap. Guided by the Institutional Analysis and Development (IAD) framework, this qualitative study used semi-structured interviews with 42 Centers for Disease Control and Prevention (CDC) and medical staff across China to examine institutional interactions and tensions in implementing the ‘Four Frees and One Care’ policy under policy overlap. The findings indicate that CDC and medical institutions exhibit divergent perceptions regarding the scope of beneficiaries for free ARVs, the allocation of responsibilities during implementation, and preferences in ARVs recommendations. CDC staff place greater emphasis on expanding antiretroviral therapy (ART) coverage to achieve public health goals for HIV control at the population level, whereas medical institutions focus more on individual treatment outcomes and the healthcare service performance. This divergence results in CDC favouring the free ARVs policy in practice, while medical institutions are more inclined toward ARVs accessed through medical insurance. Such tensions not only affect the coordination of policy implementation but may also have potential adverse impacts on PLHIV access to ART services, ART adherence, and public health outcomes.

    2026
    引用
    AI阅读
    加入学术空间
    立即登录,查看全部 762 篇论文

    高被引作者

    作者引用发文
    Gwyn Bevan4459
    Diane Mcintyre4376
    McKee Martin38223
    Filip Meheus3644
    John-Arne Røttingen3537
    Ulrika Winblad34111
    Karsten Vrangbæk33717
    Trygve Ottersen3297
    Stephen Birch3288
    Frederik T. Schut32713

    高产作者

    作者引用发文
    McKee Martin38223
    Wallenburg Iris8121
    Karsten Vrangbæk33717
    Michael K Gusmano16515
    Jan-Kees Helderman24115
    Rocco Friebel1915
    Adam Oliver5914
    Frederik T. Schut32713
    Tamara K. Hervey10312
    Richard B. Saltman15411

    相关期刊

    Journal of health politics, policy and law
    Evidence & policy : a journal of research, debate and practice
    World Medical & Health Policy (Electronic)
    International journal of health policy and management
    Health Systems & Reform
    Health Policy
    Health Policy and Technology
    International Journal of Health Governance
    Mecosan
    Evidence & Policy: A Journal of Research, Debate and Practice